RET and medullary thyroid gland carcinoma: Taking into consideration that RET is almost the only oncogene altered in MTC, it is conceivable that, if tumoral heterogeneity exists, different RET mutations might be present in different tumoral specimens (i.e., primary and metastatic tissues).